BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31837246)

  • 41. Analysis of protein-ligand interactions by fluorescence polarization.
    Rossi AM; Taylor CW
    Nat Protoc; 2011 Mar; 6(3):365-87. PubMed ID: 21372817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A TR3/Nur77 peptide-based high-throughput fluorescence polarization screen for small molecule Bcl-B inhibitors.
    Yip KW; Godoi PH; Zhai D; Garcia X; Cellitti JF; Cuddy M; Gerlic M; Chen Y; Satterthwait A; Vasile S; Sergienko E; Reed JC
    J Biomol Screen; 2008 Aug; 13(7):665-73. PubMed ID: 18626112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
    Harris A; Cox S; Burns D; Norey C
    J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells.
    Sommer G; Fedarovich A; Kota V; Rodriguez R; Smith CD; Heise T
    PLoS One; 2017; 12(3):e0173246. PubMed ID: 28291789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
    Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
    J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.
    Okada M; Tokumitsu H; Kubota Y; Kobayashi R
    Biochem Biophys Res Commun; 2002 Apr; 292(4):1023-30. PubMed ID: 11944917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting S100 Calcium-Binding Proteins with Small Molecule Inhibitors.
    Wilder PT; Varney KM; Weber DJ
    Methods Mol Biol; 2019; 1929():291-310. PubMed ID: 30710281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody.
    Turek TC; Small EC; Bryant RW; Hill WA
    Anal Biochem; 2001 Dec; 299(1):45-53. PubMed ID: 11726183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive
    Takaoka Y; Nagumo K; Azizah IN; Oura S; Iwahashi M; Kato N; Ueda M
    J Biol Chem; 2019 Mar; 294(13):5074-5081. PubMed ID: 30728246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the current value of fluorescence polarization assays in small molecule screening?
    Uri A; Nonga OE
    Expert Opin Drug Discov; 2020 Feb; 15(2):131-133. PubMed ID: 31833421
    [No Abstract]   [Full Text] [Related]  

  • 51. Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand.
    Huang X
    J Biomol Screen; 2003 Feb; 8(1):34-8. PubMed ID: 12854996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a fluorescent polarization based high throughput assay to identify new calmodulin ligands.
    Dagher R; Pigault C; Bonnet D; Boeglin D; Pourbaix C; Kilhoffer MC; Villa P; Wermuth CG; Hibert M; Haiech J
    Biochim Biophys Acta; 2006 Nov; 1763(11):1250-5. PubMed ID: 17081635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction.
    Kawamoto SA; Thompson AD; Coleska A; Nikolovska-Coleska Z; Yi H; Wang S
    Biochemistry; 2009 Oct; 48(40):9534-41. PubMed ID: 19715304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Competitive fluorescence anisotropy/polarization assay for ATP using aptamer as affinity ligand and dye-labeled ATP as fluorescence tracer.
    Li Y; Sun L; Zhao Q
    Talanta; 2017 Nov; 174():7-13. PubMed ID: 28738645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
    Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
    J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aryl acid adenylating enzymes involved in siderophore biosynthesis: fluorescence polarization assay, ligand specificity, and discovery of non-nucleoside inhibitors via high-throughput screening.
    Neres J; Wilson DJ; Celia L; Beck BJ; Aldrich CC
    Biochemistry; 2008 Nov; 47(45):11735-49. PubMed ID: 18928302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorescence polarization assay for calmodulin binding to plasma membrane Ca2+-ATPase: dependence on enzyme and Ca2+ concentrations.
    Liyanage MR; Zaidi A; Johnson CK
    Anal Biochem; 2009 Feb; 385(1):1-6. PubMed ID: 19000896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.
    Saldanha SA; Kaler G; Cottam HB; Abagyan R; Taylor SS
    Anal Chem; 2006 Dec; 78(24):8265-72. PubMed ID: 17165815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors.
    Banks P; Gosselin M; Prystay L
    J Biomol Screen; 2000 Oct; 5(5):329-34. PubMed ID: 11080691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biophysical characterization of Ca
    Kim I; Lee KO; Yun YJ; Jeong JY; Kim EH; Cheong H; Ryu KS; Kim NK; Suh JY
    Biochem Biophys Res Commun; 2017 Jan; 483(1):332-338. PubMed ID: 28017722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.